EP Patent

EP2271315A2 — Novel solid forms of bendamustine hydrochloride

Assigned to Cephalon LLC · Expires 2011-01-12 · 15y expired

What this patent protects

Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.

USPTO Abstract

Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.

Drugs covered by this patent

Patent Metadata

Patent number
EP2271315A2
Jurisdiction
EP
Classification
—
Expires
2011-01-12
Drug substance claim
No
Drug product claim
No
Assignee
Cephalon LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.